Avalo Therapeutics, Inc. Quarterly Quick Ratio in % from Q3 2018 to Q4 2023

Taxonomy & unit
ratio: %
Description
The acid-test ratio, also called the quick ratio, is a metric used to see if a company is positioned to sell assets within 90 days to meet immediate expenses.
Summary
Avalo Therapeutics, Inc. quarterly Quick Ratio history and growth rate from Q3 2018 to Q4 2023.
  • Avalo Therapeutics, Inc. Quick Ratio for the quarter ending December 31, 2023 was 0.07 %, a 49% decline year-over-year.
Quick Ratio, Quarterly (%)
Quick Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q4 2023 0.07 -0.06 -49% Dec 31, 2023
Q3 2023 0.08 -0.07 -46.2% Sep 30, 2023
Q2 2023 0.09 -0.05 -35.4% Jun 30, 2023
Q1 2023 0.11 -0.02 -15.9% Mar 31, 2023
Q4 2022 0.12 +0.04 +47% Dec 31, 2022
Q3 2022 0.15 +0.1 +211% Sep 30, 2022
Q2 2022 0.14 +0.1 +249% Jun 30, 2022
Q1 2022 0.13 +0.09 +270% Mar 31, 2022
Q4 2021 0.09 +0.02 +30.5% Dec 31, 2021
Q3 2021 0.05 -0.05 -49.8% Sep 30, 2021
Q2 2021 0.04 -0.72 -94.5% Jun 30, 2021
Q1 2021 0.03 -1.63 -97.9% Mar 31, 2021
Q4 2020 0.07 -2.67 -97.6% Dec 31, 2020
Q3 2020 0.1 -2.54 -96.3% Sep 30, 2020
Q2 2020 0.76 -2.35 -75.6% Jun 30, 2020
Q1 2020 1.66 -2.37 -58.7% Mar 31, 2020
Q4 2019 2.74 -4.75 -63.4% Dec 31, 2019
Q3 2019 2.64 -6.56 -71.3% Sep 30, 2019
Q2 2019 3.11 Jun 30, 2019
Q1 2019 4.04 Mar 31, 2019
Q4 2018 7.49 Dec 31, 2018
Q3 2018 9.2 Sep 30, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.